載入...
Efficacy of Pembrolizumab and Nivolumab in Crossing the Blood Brain Barrier
Metastatic brain tumors are the leading cause of central nervous system malignancies in adults, surpassing primary central nervous system with non-small cell lung cancer, accounting for more than 50% of all cases. The emergence of immunotherapies such as antibodies targeting the immune check points...
Na minha lista:
| 發表在: | Cureus |
|---|---|
| Main Authors: | , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Cureus
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6559690/ https://ncbi.nlm.nih.gov/pubmed/31245230 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.4446 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|